Advertisement

Pfizer submits COVID-19 vaccine for FDA approval for children five and younger

Published: May. 23, 2022 at 6:51 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

CLEVELAND, Ohio (WOIO) - Pfizer has announced their plan to submit its COVID-19 vaccine findings to the FDA, with the hope of providing the vaccine to children five and younger.

Pfizer submits COVID-19 vaccine for FDA approval for children five and younger

The announcement comes weeks after Moderna announced its plans for FDA approval on a vaccine for the same age group. https://bit.ly/3wF1pTl

Posted by Cleveland 19 News on Monday, May 23, 2022

According to the Associated Press, “Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.”

The announcement comes weeks after Moderna announced their plans for FDA approval on a vaccine for the same age group. The FDA will be looking at that on June 15th, with Pfizer coming days later.

The 18 million children in the five and under age group are the only group in the U.S. not yet qualified for the vaccine.

Dr. Amy Edwards from University Hospitals said that Pfizer is indicating the vaccine was 80% effective, however official data was not released.

Copyright 2022 WOIO. All rights reserved.